Kelly Lawrence W & Associates’s Elevance Health ELV Stock Holding History

Kelly Lawrence W & Associates’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-109,060	Closed	-$15.2M	–	165
2015 Q4	$15.2M	Buy	109,060 +2,750	+3%	+$379K	3.44%	5
2015 Q3	$14.9M	Sell	106,310 -3,460	-3%	-$520K	3.45%	4
2015 Q2	$18M	Sell	109,770 -5,715	-5%	-$913K	3.59%	3
2015 Q1	$17.8M	Sell	115,485 -7,775	-6%	-$1.11M	3.85%	3
2014 Q4	$15.5M	Sell	123,260 -3,975	-3%	-$491K	3.23%	5
2014 Q3	$15.2M	Sell	127,235 -11,550	-8%	-$1.32M	3.24%	6
2014 Q2	$14.9M	Sell	138,785 -15,950	-10%	-$1.64M	3.18%	7
2014 Q1	$15.4M	Sell	154,735 -1,025	-0.7%	-$92.7K	3.53%	6
2013 Q4	$14.4M	Sell	155,760 -7,850	-5%	-$698K	3.21%	7
2013 Q3	$13.7M	Sell	163,610 -235	-0.1%	-$20.1K	3.23%	9
2013 Q2	$13.4M	Buy	+163,845	New	+$12.3M	3.4%	4

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kelly Lawrence W & Associates's ELV Position: Q1 2016 in Review

Kelly Lawrence W & Associates sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 109,060 shares — an estimated $15.2M sold.

Kelly Lawrence W & Associates first reported a position in ELV in Q2 2013 and held it in 11 quarters. The position peaked at $18M in Q2 2015. 771 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

Kelly Lawrence W & Associates reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
Kelly Lawrence W & Associates sold 109,060 Elevance Health shares in Q1 2016, an estimated $15.2M.
Kelly Lawrence W & Associates first reported a position in Elevance Health in Q2 2013 and held it in 11 quarters.
Kelly Lawrence W & Associates's Elevance Health position peaked at $18M in Q2 2015.
771 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2016, filed 16 May 2016.